文献速递泌尿系结石

门诊输尿管镜碎石术后新发持续阿片类药物使用

New Persistent Opioid Use After Outpatient Ureteroscopy for Upper Tract Stone Treatment.
PubMed 文献 · Urology · 2019-09-16

该研究利用理赔数据分析了2008至2016年间接受门诊输尿管镜(URS)治疗上尿路结石的成人,发现51.2%的患者为阿片类药物初治。在初治患者中,6.2%(近1/16)出现新发持续阿片使用,且URS时处方阿片量最高三分位者新发持续使用的比值比是最低三分位的1.69倍(95%CI 1.41-2.03)。

要点

  • 近1/16阿片初治患者URS后出现新发持续阿片使用。
  • URS时阿片处方量越高,新发持续使用风险越高。
  • 泌尿外科医生应重新评估URS术后阿片处方模式。

核心结论

  • 门诊URS后近1/16阿片初治患者出现新发持续阿片使用,且与URS时处方阿片量相关。

主要发现

  • 51.2%的患者为阿片初治,其中6.2%出现新发持续阿片使用(URS后91-180天继续使用)。
  • 新发持续使用者在术后6个月仍续方,日剂量为4.2口服吗啡当量。
  • 调整社会人口学和临床差异后,URS时阿片处方量最高三分位者新发持续使用的比值比为1.69(95%CI 1.41-2.03),相比最低三分位。

关键数值与推荐

  • 新发持续阿片使用定义为阿片初治患者在URS后91-180天继续使用阿片。
  • 最高三分位阿片处方量对比最低三分位,新发持续使用比值比1.69(95%CI 1.41-2.03)。
  • 术后6个月持续使用者日剂量为4.2口服吗啡当量。

临床怎么用

  • 泌尿外科医生应重新评估URS术后阿片处方模式,以减少新发持续阿片使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To measure the incidence of persistent opioid use following ureteroscopy (URS). Over 100 Americans die every day from opioid overdose. Recent studies suggest that many opioid addictions surface after surgery. METHODS: Using claims data, we identified adults who underwent outpatient URS for treatment of upper tract stones between January 2008 and December 2016 and filled an opioid prescription attributable to URS. We then measured the rate of new persistent opioid use-defined as continued use of opioids 91-180 days after URS among those who were previously opioid-naive. Finally, we fit multivariable models to assess whether new persistent opioid use was associated with the amount of opioid prescribed at the time of URS. RESULTS: In total, 27,740 patients underwent outpatient URS, 51.2% of whom were opioid-naïve. Nearly 1 in 16 (6.2%) opioid-naïve patients developed new persistent opioid use after URS. Six months following surgery, beneficiaries with new persistent opioid use continued to fill prescriptions with daily doses of 4.2 oral morphine equivalents. Adjusting for measured sociodemographic and clinical differences, patients in the highest tercile of opioids prescribed at the time of URS had 69% higher odds of new persistent opioid use compared to those in the lowest tercile (odds ratio, 1.69; 95% CI, 1.41-2.03). CONCLUSION: Nearly 1 in 16 opioid-naive patients develop new persistent opioid use after URS. New persistent opioid use is associated with the amount of opioid prescribed at the time of URS. Given these findings, urologists should re-evaluate their post-URS opioid prescribing patterns.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Tam CA, Dauw CA, Ghani KR, et al. New Persistent Opioid Use After Outpatient Ureteroscopy for Upper Tract Stone Treatment. Urology. 2019. PMID: 31536742. doi:10.1016/j.urology.2019.08.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。